XXYLT1-AS2
gene geneOn this page
Summary
XXYLT1-AS2 (XXYLT1 antisense RNA 2, HGNC:41154) is a long non-coding RNA gene on chromosome 3q29.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:41154 |
| Approved symbol | XXYLT1-AS2 |
| Name | XXYLT1 antisense RNA 2 |
| Location | 3q29 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000230266 |
| Ensembl biotype | lncRNA |
| Entrez | 101410543 |
| RNAcentral | URS000075AF6F — lncRNA, 859 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 lncRNA
ENST00000426468, ENST00000447975
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000426468 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004172105 | 195147723 | 195148105 |
| ENSE00004172106 | 195152257 | 195152858 |
Expression profiles
Bgee: expression breadth ubiquitous, 122 present calls, max score 76.81.
FANTOM5 (CAGE): breadth broad, TPM avg 1.0756 / max 34.9268, expressed in 240 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 40681 | 0.8051 | 206 |
| 40683 | 0.1252 | 78 |
| 40682 | 0.0836 | 65 |
| 40680 | 0.0618 | 29 |
Top tissues by expression
122 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lymph node | UBERON:0000029 | 76.81 | gold quality |
| stromal cell of endometrium | CL:0002255 | 75.75 | gold quality |
| bone marrow cell | CL:0002092 | 69.69 | silver quality |
| cortical plate | UBERON:0005343 | 69.33 | gold quality |
| body of stomach | UBERON:0001161 | 68.50 | gold quality |
| tonsil | UBERON:0002372 | 67.20 | gold quality |
| stomach | UBERON:0000945 | 67.16 | gold quality |
| monocyte | CL:0000576 | 67.00 | gold quality |
| vermiform appendix | UBERON:0001154 | 66.40 | gold quality |
| leukocyte | CL:0000738 | 66.35 | gold quality |
| placenta | UBERON:0001987 | 65.21 | gold quality |
| bone marrow | UBERON:0002371 | 64.78 | gold quality |
| fundus of stomach | UBERON:0001160 | 64.42 | gold quality |
| colonic epithelium | UBERON:0000397 | 64.30 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 64.19 | silver quality |
| lower esophagus muscularis layer | UBERON:0035833 | 63.86 | gold quality |
| lower esophagus | UBERON:0013473 | 63.70 | gold quality |
| mucosa of stomach | UBERON:0001199 | 63.51 | gold quality |
| gall bladder | UBERON:0002110 | 62.83 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 62.35 | gold quality |
| granulocyte | CL:0000094 | 62.09 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 61.37 | gold quality |
| small intestine | UBERON:0002108 | 60.34 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 60.33 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 60.31 | gold quality |
| rectum | UBERON:0001052 | 59.48 | gold quality |
| esophagus | UBERON:0001043 | 59.30 | gold quality |
| calcaneal tendon | UBERON:0003701 | 59.15 | gold quality |
| intestine | UBERON:0000160 | 58.49 | gold quality |
| blood | UBERON:0000178 | 58.15 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.32 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Long noncoding RNA XXYLT1-AS2 regulates proliferation and adhesion by targeting the RNA binding protein FUS in HUVEC. (PMID:32171981)
- LncRNA XXYLT1-AS2 promotes tumor progression via autophagy inhibition through ubiquitinated degradation of TFEB in hepatocellular carcinoma. (PMID:37540409)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.